AI / Methods2 days agoNew
Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy.
A recent review identifies mRNA-lipid nanoparticle systems as offering distinct advantages for personalized cancer vaccines, including rapid manufacturing and potent antigen expression. The authors propose combining these delivery platforms with cytokine engineering and T cell modulation to enhance immunogenicity. This synthesis addresses critical challenges in antigen selection and clinical translation that have hindered broader adoption of personalized vaccines.